Identification | More | [Name]
Tiamulin | [CAS]
55297-95-5 | [Synonyms]
(1S,2R,3S,4S,6R,7S,14R)-6-[(2-DIETHYLAMINOETHYLTHIO)ACETOXY]-3-HYDROXY-2,4,7,14-TETRAMETHYL-4-VINYLTRICYCLO[5,4,3,01.8]TETRADECAN-9-ONE 5-hydroxy-4,6,9,10-tetramethyl-1-oxo-6-vinyldecahydro-3a,9-propanocyclopenta[8]annulen-8-yl hydroxyacetate drosophilin b TIAMULIN ,10-tetramethyl-1-oxo-3a,9-propano-3ah-cyclopentacycloocten-8-ylester,(3as-( 14-deoxy-14-((2-diethylaminoethyl-thio)-acetoxy)mutiline 4-beta,5-alpha,6-alpha,8-beta,9-beta,10s*))-3a-alph aceticacid,((2-(diethylamino)ethyl)thio)-,6-ethenyldecahydro-5-hydroxy-4,6,9 sq14055 thiamutilin tiamulina tiavetp Tiamutin Acetic acid, 2-(diethylamino)ethylthio-, (3aS,4R,5S,6S,8R,9R,9aR,10R)-6-ethenyldecahydro-5-hydroxy-4,6,9,10-tetramethyl-1-oxo-3a,9-propano-3aH-cyclopentacycloocten-8-yl ester (1s,2r,3s,4s,6r,7s,14r)-6-[(2-diethylaminoethylthio)acetoxy]-3-hydroxy-2,4,7,14-tetramethyl-4-vinyltricyclo[5,4,3,01.8]tetradecan-9-one TIAMILIN (3aS,4R,5S,6S,8R,9R,9aR,10R)-Decahydro-8-[[2-(diethylamino)ethyl]thio]acetyloxy-5-hydroxy-4,6,9,10-tetramethyl-6-vinyl-3a,9-propano-3aH-cyclopentacycloocten-1-one [[2-(Diethylamino)ethyl]thio]acetic acid [(3aS,10R,9aβ)-6α-ethenyldecahydro-5α-hydroxy-4β,6,9,10-tetramethyl-1-oxo-3aα,9α-propano-3aH-cyclopentacycloocten]-8β-yl ester [[2-(Diethylamino)ethyl]thio]acetic acid [(3aS,9aβ,10R)-6α-ethenyldecahydro-5α-hydroxy-4β,6,9,10-tetramethyl-1-oxo-3aα,9α-propano-3aH-cyclopentacycloocten]-8β-yl ester [2-(Diethylamino)ethylthio]acetic acid [(3aS,9aβ,10R)-6α-ethenyldecahydro-5α-hydroxy-4β,6,9,10-tetramethyl-1-oxo-3aα,9α-propano-3aH-cyclopentacycloocten]-8β-yl ester | [EINECS(EC#)]
259-580-0 | [Molecular Formula]
C28H47NO4S | [MDL Number]
MFCD01672098 | [Molecular Weight]
493.74 | [MOL File]
55297-95-5.mol |
Safety Data | Back Directory | [WGK Germany ]
2 | [RTECS ]
AG9552000 | [HS Code ]
2941906000 | [Safety Profile]
Poison by
intramuscular and intravenous routes.
Moderately toxic by ingestion and
subcutaneous routes. When heated to
decomposition it emits toxic fumes of SOx
and NOx. See also MERCAPTANS. | [Hazardous Substances Data]
55297-95-5(Hazardous Substances Data) |
Hazard Information | Back Directory | [Uses]
Tiamulin is a derivative of Pleuromutilin. Antibacterial. | [Uses]
Tiamulin is a semi–synthetic analogue of pleuromutilin in which the hydroxyacetyl side chain is replaced with a larger diethylaminoethylthioacetyl moiety, providing greater hydrophobicity and an ionisable group for salt formation and greater water solubility. Tiamulin is a potent and highly selective antibiotic active against a range of Gram positive bacteria, with no cross resistance to existing antibiotic classes due to its unique mode of action. Like pleuromutilin, it inhibits protein synthesis by binding to domain V of 23S rRNA. | [Definition]
ChEBI: A carbotricyclic compound that is pleuromutilin in which the hydroxyacetate group is replaced by a 2-{[2-(diethylamino)ethyl]sulfanyl}acetate group. An antibacterial drug, tiamulin is used in veterinary medicine (generally as its hydrogen fumarate salt) fo
the treatment of swine dysentery caused by Serpulina hyodysenteriae. | [General Description]
Tiamulin has been developed by that company in collaboration with E.R. Squibb & Sons for use against animal infec tions. Tiamulin is used against dysentery and Mycoplasma infections in sheep, swine, cattle, and chickens. | [Synthesis]
Tiamulin was synthesized by Sandoz Co. in 1973, starting from pleuromutilin produced by Pleurotus mutilus. | [Veterinary Drugs and Treatments]
Tiamulin is approved for use in swine to treat pneumonia caused
by susceptible strains of Haemophilus pleuropneumoniae and swine
dysentery caused by Treponema hyodysenteriae. As a feed additive, it
is used to cause increased weight gain in swine. |
|
|